Company: SXTPW
Filing Date: 2025-07-07
Form Type: S-1
Source: 0001213900-25-061842
Chunk: 4

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-07
Form: S-1
Chunk 4
---
 “Placement Agent Warrants”) issuable to H.C. Wainwright &
Co., LLC (the “placement agent”) as compensation in connection with the placement agent’s services in this offering,
and the shares of common stock issuable upon the exercise of the Placement Agent Warrants.

Our common stock is listed on The Nasdaq Capital
Market under the symbol “SXTP.” The last reported sale price of our common stock on The Nasdaq Capital Market on July 2, 2025
was $2.455 per share.

There is no established public trading market
for the Warrants or Pre-Funded Warrants. We do not intend to apply to list the Pre-Funded Warrants or the Warrants on any national securities
exchange or other nationally recognized trading system. Without an active trading market, the liquidity of the Pre-Funded Warrants and
the Warrants will be limited.

This offering will terminate on August 30, 2025,
unless we decide to terminate the offering (which we may do at any time in our discretion) prior to that date. We expect to have a single
closing for all the securities purchased in this offering. We will deliver all securities to be issued in connection with this offering
delivery versus payment/receipt versus payment upon receipt by us of investor funds. Accordingly, neither we nor the placement agent have
made any arrangements to place investor funds in an escrow account or trust account since the placement agent will not receive investor
funds in connection with the sale of the securities offered hereunder.

The combined offering price per share of common
stock and accompanying Warrants and the combined offering price per Pre-Funded Warrant and accompanying Warrants we are offering and the
exercise price and other terms of the Warrants were negotiated between us and the purchasers, in consultation with the placement agent
based on the trading of our common stock prior to this offering, among other factors. Other factors considered in determining the offering
price of the securities we are offering and the exercise price and other terms of the Warrants include the history and prospects of our
company, the stage of development of our business, our business plans for the future and the extent to which they have been implemented,
an assessment of our management, general conditions of the securities markets at the time of the offering and such other factors as were
deemed relevant.

We have engaged H.C. Wainwright & Co., LLC
as our exclusive placement agent to use its reasonable best efforts to solicit offers to purchase our securities in this